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Abstract
Chemoprevention by naturally occurring agents is a
newer dimension in the management of neoplasia,
including skin cancer. Solar ultraviolet (UV) radiation
is the major cause of skin cancer. We recently demon-
strated that resveratrol (3,5,40 - trihydroxystilbene), a
polyphenolic antioxidant found in grapes and red wine,
imparts protection from UVB-mediated cutaneous dam-
ages in SKH-1 hairless mice. The mechanism of action
of resveratrol is not clearly understood. Here, we
investigated the involvement of nuclear factor kappa B
(NF-KB), which is known to play a critical role in skin
biology and the development of skin cancer, as the
mechanism of chemoprevention of UV damage by
resveratrol. In the normal human epidermal keratino-
cytes, resveratrol blocked UVB-mediated (40 mJ/cm2)
activation of NF-KB in a dose-dependent (5, 10, and 25
mM resveratrol for 24 hours) as well as time-dependent
(5 mM resveratrol for 12, 24, and 48 hours) fashion.
Resveratrol treatment of keratinocytes also inhibited
UVB-mediated 1) phosphorylation and degradation of
IKBa, and 2) activation of IKKa. We suggest that NF-KB
pathway plays a critical role in the chemopreventive
effects of resveratrol against the adverse effects of UV
radiation including photocarcinogenesis.
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Introduction
In the US, nonmelanoma skin cancer, which includes basal
and squamous cell carcinoma, is the most frequently diag-
nosed form of cancer accounting for nearly half of all cancer
types [1]. According to an estimate, more than a million
new cases of skin cancers are diagnosed annually in the
US [1]. The epidemiological studies have shown that there
is an increased risk of several other lethal cancer types in
the individuals with a history of skin cancer [2]. Therefore,
it is warranted to intensify our efforts for the development of
novel approaches for prevention and therapy of this cancer
type.
Chemoprevention by naturally occurring compounds (at
nontoxic dose) appears to be a potential strategy for the
management of neoplasia [3–5]. The expanded horizon of
cancer chemoprevention also includes the chemotherapy of
precancerous lesions [5]. Our recent work has demonstrated
that a topical application of resveratrol ( trans -3,40,5 - trihy-
droxystilbene) to SKH-1 hairless mice results in significant
inhibitions of ultraviolet (UV) B-mediated 1) skin edema, 2)
inflammation, 3) cyclooxygenase (COX) and ornithine decar-
boxylase (ODC) induction, and 4) generation of hydrogen
peroxide (H2O2) and lipid peroxidation in the skin [6 ].
However, the mechanism of the action of resveratrol is not
clearly understood.
The nuclear transcription factor nuclear factor kappa B
(NF-kB; a redox-sensitive transcriptional factor ) is known to
play a critical role in the pathogenesis of cancer and many
other pathological conditions [7–11], inasmuch as it is being
extensively investigated as a potential target of anticancer
drug design [11]. In fact, in the skin, NF-kB plays a par-
ticularly central role in epidermal biology (see Ref. [12] ). It is
believed that, perpetually subjected to the harmful UV rays of
the sun, the proliferative cells of the epidermis may rely on
NF-kB activation for protection and survival (see Ref. [12] ).
This study was designed to investigate our hypothesis that
NF-kB plays a critical role in the chemoprevention of UV
damages imparted by resveratrol.
Thus, the genesis and rationale for this work are based on
three important facts: 1) solar UV radiation, which is known to
cause the generation of many reactive oxygen species
(ROS), is the major cause of skin cancer and many other
skin- related hyperproliferative disorders such as actinic
keratoses that are regarded to be the precursor of neoplastic
condition [13,14]; 2) the nuclear transcription factor NF-kB is
known to play key role in skin biology and development of
cancer [12]; and 3) resveratrol (Figure 1) — a naturally
occurring polyphenolic phytoalexin found in grapes, red wine,
peanuts, mulberries, and fruits — is an exceptionally strong
antioxidant that has shown promise for the management
of certain cancer types including skin cancer [15–17]. Fur-
ther, our recent studies have shown that resveratrol imparts
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prevention from the damages caused by UVB radiation in a
mouse model [6 ].
We employed the normal human epidermal keratinocytes
for our present work. Our choice of cells is based on the fact
that cancer begins in normal cells and, therefore, the
chemoprevention studies should be conducted in normal
cells. Our data demonstrated that resveratrol inhibits UVB-
mediated activation of NF-kB pathway. Therefore, we sug-
gest that resveratrol imparts chemopreventive effects for UV
responses that include skin carcinogenesis, at least in part,
through the inhibition of NF-kB activation by blocking IkB
kinase ( IKK) degradation of IkBa. Our study provides a
molecular basis for the chemopreventive effects of resver-
atrol against skin carcinogenesis, in particular, and the
process of oncogenesis, in general.
Materials and Methods
Reagents
Resveratrol (>99% pure) was purchased from Sigma (St.
Louis, MO). The antibodies against IkBa and phospho- IkBa
were purchased New England Biolaboratories, (Beverly,
MA). NF-kB/p65 antibody was obtained from Geneka
Biotechnology (Montreal, Canada) and IKKa antibody was
purchased from Santa Cruz Biotechnology (Santa Cruz,
CA). The DC Bio-Rad protein assay kit was obtained
from Bio-Rad Laboratories (Hercules, CA). Electrophoretic
mobility shift assay (EMSA) kit was purchased from
Geneka Biotechnology. Enzyme- linked immunosorbent as-
say (ELISA) kit for NF-kB/p65 was purchased from Pierce
(Rockford, IL). The precast Tris–glycine gels and chemi-
luminescence detection kits were obtained from Amersham
Life Science (Arlington Heights, IL).
Cell Culture
The normal human epidermal keratinocytes were iso-
lated from neonatal foreskin specimens as described earlier
[18], and primary cultures were initiated and maintained in
a replicative state with complete, serum-free MCDB 153
keratinocyte medium. Complete medium was supplemented
with 0.1 mM calcium, 0.2% (vol /vol ) bovine pituitary extract,
10 ng/ml EGF, 5 mg/ml insulin, 5107 M hydrocortisone,
1104 M ethanolamine, and 1104 M phosphoethanol-
amine, and supplemented with amino acids [19]. Cells were
grown until they were 60% to 80% confluent, at which time
they were subjected to different treatment protocols.
UVB Source
The UVB sources employed in this study were FS40
lamps (Westinghouse, Pittsburgh, PA), which emit an energy
spectrum with high fluency in the UVB region (with a peak
at 313 nm). UV radiation that is not normally present in
natural solar light was filtered out using Kodacel cellulose
film. After filtration with Kodacel film, the majority of the
resulting wavelengths of UV radiation were in the range of
290 to 320 nm. The emitted UVB dose was regularly quan-
titated with an IL-443 phototherapy radiometer ( Interna-
tional Light, Newburyport, MA) equipped with an IL SED 240
detector fitted with a W side-angle quartz diffuser and an
SC5 280 filter.
Treatment of Cells
Resveratrol (dissolved in DMSO) was used for the
treatment of cells. For dose-dependent studies, the cells
(70–80% confluent ) were treated with resveratrol (0, 5, 10,
and 25 M) for 24 hours. Twenty- four hours following
treatment with resveratrol, the cells were washed with
phosphate-buffered saline (PBS; pH 7.4) and exposed to
UVB (40 mJ/cm2). Six hours following UVB exposure, cells
were harvested, lysed, and nuclear and cytosolic (post-
nuclear) fractions were prepared. For time-dependent
studies, the cells (50–60% confluent ) were treated with 5
M resveratrol for 12, 24, and 48 hours and then washed with
PBS and exposed to UVB (40 mJ/cm2). Six hours following
UVB exposure, the cells were harvested, and nuclear and
cytosolic cellular lysates were prepared.
Preparation of Nuclear and Cytosolic Lysates
For the preparation of nuclear and postnuclear fractions,
the cells were washed with cold PBS (pH 7.4) and
suspended in 0.4 ml of lysis buffer (10 mM HEPES, pH
7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT,
0.5 mM phenylmethylsulfonyl fluoride, 2.0 g/ml leupeptin,
2.0 g/ml aprotinin, 0.5 mg/ml benzamidine) in a microfuge
tube. The cells were incubated on ice for 15 minutes, after
which 12.5 l of 10% Nonidet P-40 was added and the
contents were mixed on a vortex and then centrifuged for 1
min at 48C at 14,000g. The supernatant was saved as
‘‘postnuclear fraction’’ and stored at 808C. The nuclear
pellet was resuspended in 25 l of ice-cold nuclear
extraction buffer (20 mM HEPES, pH 7.9, 0.4 M NaCl, 1
mM EDTA, 1 mM EGTA, 1 mM DTT, 1 mM PMSF, 2.0 g/ml
leupeptin, 2.0 g/ml aprotinin, 0.5 mg/ml benzamidine) and
incubated on ice for 30 minutes with intermittent mixing. The
tube was centrifuged for 5 minutes at 14,000g at 48C and the
supernatant (nuclear extract) was stored at 808C. The
protein concentration was determined by the DC Bio-Rad
assay (Bio-Rad Laboratories) as per the manufacturer’s
protocol.
OH
OH
OH
Chemical Structure of trans-Resveratrol 
(3,5,4'-trihydroxystilbene)
Figure 1. Chemical structure of trans - resveratrol.
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Immunoblot Analysis
For Immunoblot analysis, 30 to 50 g of protein was
resolved over 8% to 12% Tris–glycine gels and transferred
onto a nitrocellulose membrane. The nonspecific sites were
blocked by incubating the blot with 5% nonfat dry milk in
buffer (10 mM Tris, 100 mM NaCl, 0.1% Tween-20) for 1
hour at room temperature or overnight at 48C. The blot was
washed with wash buffer (10 mM Tris, 100 mM NaCl, 0.1%
Tween-20) for 210 minutes and then incubated overnight
with appropriate primary antibody specific for the protein to
be assessed. The antibodies were used at dilutions specified
by the manufacturer. The blot was washed for 210 minutes
and then incubated with the corresponding secondary anti-
body HRP conjugate (Amersham Life Science) at 1:2000
dilution for 1 hour at room temperature. The blot was washed
for 210 and 45 minutes, and the protein was detected by
chemiluminescence using ECL kit (Amersham Life Science)
and autoradiography with XAR-5 film (Amersham Life
Science). For every immunoblot, equal loading of protein
was confirmed by stripping the blot and reprobing with
b -actin antibody.
Electromobility Shift Assay
EMSA for NF-kB/p65 was performed by employing
Lightshift2 Chemiluminescent EMSA kit (Pierce) as per
the manufacturer’s protocol. Briefly, to start with, DNA was
biotin- labeled using the Biotin 30 end labeling kit (Pierce). In
a 50-l reaction buffer in a microfuge tube, 5 pmol of double-
stranded NF-kB oligonucleotide 50 -AGTTGAGGG GACT-
TTCCCAGGC-30; 30 -TCAACTCCCCTGAAAGGGTCCG-50
was incubated in 10 l of 5 TdT ( terminal deoxynucleotidyl
transferase) buffer, 5 l of 5 M biotin-N4-CTP, 10 U of
diluted TdT, and 25 l of ultrapure water at 378C for 30
minutes. The reaction was stopped with 2.5 l of 0.2 M
EDTA. To extract labeled DNA, 50 l of chloroform:isoamyl
alcohol (24:1) was added to each tube followed by
centrifugation briefly at 13,000g. The top aqueous phase
containing the labeled DNA was removed and saved for
binding reactions. Each binding reaction contained 1 bin-
ding buffer (100 mM Tris, 500 mM KCl, 10 mM dithio-
threitol, pH 7.5), 2.5% glycerol, 5 mM MgCl2, 50 ng/l poly
(dI–dC), 0.05% NP-40, 2 to 3 l of nuclear extract, and
20 to 50 fmol of biotin end- labeled target DNA. Binding
reactions were incubated at room temperature for 20 mi-
nutes. To this reaction mixture was added 5 l of 5 loading
buffer, and the content was subjected to gel electro-
phoresis on a native polyacrylamide gel and transferred to
a nylon membrane. When the transfer was complete,
DNA was cross- linked to the membrane at 120 mJ/cm2
using a UV cross- linker equipped with 254-nm bulbs. The
biotin end- labeled DNA was detected using streptavidin–
horseradish peroxidase conjugate and a chemiluminescent
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Figure 2. Effect of resveratrol on UVB-mediated activation of NF -B /p65: immunoblot analysis. The normal human keratinocytes were treated with resveratrol ( 5,
10, and 25 M for 24 hours for dose -dependent studies or 5 M for 12, 24, and 48 hours for time -dependent studies ) after which the cells were washed and exposed
to UVB radiation in PBS. Six hours following UVB exposure, the nuclear lysates were prepared. The immunoblot analysis was performed for NF -B/p65 using
appropriate antibodies as described under Materials and Methods. For every immunoblot, equal loading of protein was confirmed by stripping the blot and reprobing
with  - actin antibody ( data not shown ). The data shown here are from representative experiment repeated four times with similar results.
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substrate. The membrane was exposed to X-ray film
(XAR-5; Amersham Life Science) and developed with a
Kodak film processor.
ELISA for NF-kB/p65
For the detection of NF-kB/p65 by ELISA, we employed
commercially available Trans-AM kit (Active Motif, Carls-
bad, CA) using the vendor’s protocol. The assay system
uses an oligonucleotide containing NF-kB consensus site
(50 -GGGACTTTCC-30 ) that binds to the nuclear extract
and can detect NF-kB, which can recognize an epitope on
activated p65 bound to its target DNA. In the absence of
the competitive binding with the wild- type or mutated con-
sensus oligonucleotide, 30 l of binding buffer was added
to each well in duplicate. Alternatively, 30 l of binding
buffer containing 20 pmol (2 l ) of appropriate oligonu-
cleotide, in duplicate, was added to corresponding well.
Ten-micrograms of protein from the nuclear lysate of each
sample was diluted in 20 l of lysis buffer and added to
each well. For positive control, 20 l of lysis buffer con-
taining 1 l of control cell extract was added per well. For
blank, 20 l of lysis buffer per well was used. The plate was
covered with a sealer and incubated for 1 hour at room
temperature with mild agitation (100 rpm on a rocking plat-
form). Each well was washed three times with 200 l of 1
wash buffer. One hundred microliters of diluted primary
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Figure 3. Effect of resveratrol on UVB - induced activation of NF -B: EMSA. The normal human keratinocytes were treated with resveratrol ( 5, 10, and 25 M for 24
hours for dose -dependent studies or 5 M for 12, 24, and 48 hours for time -dependent studies ) after which the cells were washed and exposed to UVB radiation in
PBS. Six hours following UVB exposure, the nuclear lysates were prepared. The EMSA was performed as detailed under Materials and Methods. C1, C2 and C3
represent controls; biotin –EBNA control DNA, biotin –EBNA control DNA+EBNA extract, biotin –EBNA control DNA+EBNA extract +200 - fold molar excess of
unlabeled EBNA DNA, respectively. The data shown here are from representative experiment repeated three times with similar results.
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antibody (1:1000 dilution in 1 antibody-binding buffer )
was added to each well and incubated at room temperature
for 1 hour without agitation. The wells were washed again
three times with 1 wash buffer. Then, 100 l of diluted HRP
conjugate antibody (1:1000 dilution in 1 antibody binding
buffer ) was added to each well and incubated for 1 hour. The
wells were again washed four times with 1 wash buffer
followed by an addition of 100 l of developing solution.
The content was incubated for 5 minutes at room temper-
ature, which developed a blue color in the samples and pos-
itive control wells. One hundred microliters of stop solution
was added to each well and the absorbance was read at
450 nm.
Results and Discussion
In the recent past, chemoprevention by naturally occur-
ring nontoxic agents found in the diets and beverages has
been appreciated as a potential strategy for the manage-
ment of neoplasia including skin cancer [3–5]. Resveratrol
(Figure 1) is a polyphenolic compound found in a variety of
fruits and vegetables and is abundant in grapes and red
wine. Some epidemiological studies have suggested the
cardioprotective and chemopreventive properties of resver-
atrol (see Ref. [1 ] ). The lower risk of heart diseases and
cancer in certain populations, e.g., the French and the
Greek, has been linked with a regular consumption of red
wine ( rich in resveratrol; concentration 10–20 M), a
phenomenon dubbed as French paradox [20–25]. Resver-
atrol has been shown to possess strong antiproliferative and
anti - inflammatory properties in some assay systems [17].
Studies have shown that resveratrol imparts skin cancer
chemopreventive action by inhibiting cellular events at all the
three stages ( initiation, promotion, and progression) of the
process of carcinogenesis [16]. Jang et al. [16], in the year
1997, have shown that topical application of resveratrol
affords substantial protection against chemically induced
skin carcinogenesis in CD-1 mice. Our recent studies have
shown that resveratrol imparts prevention of the UVB
radiation-mediated damages, which are regarded to be
critical in the development of skin cancer, in the SKH-1
hairless mouse skin [6 ]. How resveratrol exerts its chemo-
preventive effects is only partially understood.
Because the inflammatory, growth-modulatory, and on-
cogenic effects of many chemicals are mediated through
NF-kB [7–11], we hypothesized that the inhibition of NF-kB
pathway is responsible for the chemopreventive effects of
resveratrol against UVB-mediated damages in skin includ-
ing skin carcinogenesis. Many lines of evidence suggest in
favor of this possibility. For example, a variety of agents,
which promote tumorigenesis (such as UV radiation, phorbol
ester, okadaic acid, and TNF-a ), are known to activate NF-
kB (see Refs. [22,26] ). It is also important to mention here
that resveratrol has been shown to block the activation of
NF-kB in certain cell types [22]. Further, several genes that
are involved in oncogenesis, tumor metastasis, and inflam-
mation are regulated by NF-kB [22,26]. Studies have also
demonstrated a critical role for NF-kB in cellular trans-
formation [27].
To start with our experimental strategy, in dose- as well
as time-dependent protocols, we first evaluated the effect of
resveratrol on UVB-mediated modulation in NF-kB. We
used multiple methods to achieve our goal. As shown by the
data in Figure 2, the immunoblot analysis of the nuclear cell
0
0.04
0.08
0.12
0.16
N
F-
B
 
a
c
tiv
a
tio
n
 
(O
D
45
0n
m
)
Resveratrol (  μM)      - 5  10    25  - 5 10 25 
UVB (40mJ/cm2)    - - - - + +  +  +
0
0.04
0.08
0.12
0.16
N
F-
B
 
a
c
tiv
a
tio
n
 
(O
D
45
0n
m
)
Resveratrol (5  μM)     - 12     24 48   - 12    24 48 h
UVB (40mJ/cm2)         - - - - +     +  +  +
Dose-dependent Time-dependent
κ κ
Figure 4. Effect of resveratrol on UVB- induced activation of NF -B /p65: ELISA. The normal human keratinocytes were treated with resveratrol ( 5, 10, and 25 M
for 24 hours for dose -dependent studies or 5 M for 12, 24, and 48 hours for time -dependent studies ) after which the cells were washed and exposed to UVB
radiation in PBS. Six hours following UVB exposure, the nuclear lysates were prepared for ELISA. The effect on NF-B/p65 was evaluated using ELISA as detailed
in Materials and Methods. The data are expressed as mean±SEM from four experiments, conducted at least in triplicate.
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lysates (obtained from the treated and control cells ) clearly
demonstrated that a 40-mJ/cm2 (a near physiological dose)
dose of UVB radiation results is a significant activation of
NF-kB/p65. A prior treatment of the keratinocytes with
resveratrol resulted in a significant dose-dependent (5, 10,
and 25 M for 24 hours) as well as time-dependent (12, 24,
and 48 hours of treatment with 5 M resveratrol ) inhibition
of NF-kB activation. Similar results were obtained when
we measured the effect of resveratrol on UVB-mediated
modulations in keratinocyte employing EMSA (Figure 3)
and ELISA (Figure 4). This is an important information
because NF-kB is a redox-sensitive transcriptional factor
[28,29], which is activated in response to a change in
the redox status of the cells ( in favor of oxidants) as a result
of an oxidative stress condition. UVB exposure to the
skin is known to produce oxidative stress in the cells [30].
Our recent studies have shown that in mouse skin, UVB
exposure results in the generation of H2O2 and lipid pero-
xides (LPOs); and the pretreatment of skin with resveratrol
significantly prevents damages to the skin [6 ]. This study,
together with our present observations, suggests that res-
veratrol imparts chemoprevention of UVB-mediated dam-
ages to the skin through inhibition of NF-kB activation and its
subsequent nuclear translocation.
Currently, NF-kB is regarded as a target for anticancer
drug design [11]. It is important to mention here that NF-kB
plays a critical role in epidermal biology [12]. It is believed
that, perpetually subjected to the harmful UVB exposure,
the proliferative cells of the epidermis may rely on NF-kB
activation for protection and survival (Ref. [12] and refe-
rences therein). Recently, gain or loss of function studies in
mice suggest an equally important role in balancing growth
and differentiation in the epidermis (see Ref. [12] ). Mice that
are null for each of the Rel family members have been ge-
nerated. The p65 single and double null mice die by E16 at a
time when epidermal stratification and differentiation are still
developing, suggesting a connection of this targeting event
with epidermal differentiation (see Ref. [12] ).
It is well known that in a living cell, NF-kB is present in
the cytoplasm in the form of a complex with its inhibitory
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Figure 5. Effect of resveratrol on UVB- induced degradation and phosphorylation of IB. The normal human keratinocytes were treated with resveratrol ( 5, 10, and
25 M for 24 hours for dose -dependent studies or 5 M for 12, 24, and 48 hours for time -dependent studies ) after which the cells were washed and exposed to UVB
radiation in PBS. Six hours following UVB exposure, the postnuclear lysates ( cytosol ) were prepared. The immunoblot analysis was performed for IB or phospho -
IB using appropriate antibodies as described under Materials and Methods. For every immunoblot, equal loading of protein was confirmed by stripping the blot and
reprobing with  - actin antibody ( data not shown ). The data shown here are from representative experiment repeated four times with similar results.
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protein IkBa [7–11]. This complex has been shown to pri-
marily exist in an inactive stage, and upon activation, IkBa
undergoes a phosphorylative degradation through an ubiq-
uitin -dependent pathway, which results in a translocation
of NF-kB to nucleus [7–11]. In the nucleus, NF-kB acti-
vates a variety of genes responsible for different physio-
logical functions [7–11]. In the next series of experiments,
we evaluated the effect of resveratrol on UVB exposure-
mediated modulation in IkBa in normal human keratino-
cytes. As shown by the immunoblot analysis (Figure 5),
UVB exposure (40 mJ/cm2) to the keratinocytes was
found to result in a significant decrease in the level of IkBa
in the cytosol (postnuclear cell lysate), and pretreatment
of keratinocytes with resveratrol resulted in a dose- as well
as time-dependent restoration of IkBa degradation. IkBa
(a 35- to 37-kDa protein) is the most widely studied mem-
ber of the IkB family of proteins that is known to bind to the
p65 subunit of p50–p65 heterocomplex through ankyrin
repeats [31,32]. The phosphorylative degradation, through
the phosphorylation at serine-32 of IkBa, is a major me-
chanism of NF-kB activation [33]. Therefore, employing
a phospho-specific antibody that was raised against a
peptide corresponding to a short amino acid sequence
containing phosphorylated serine-32 of IkBa of human
origin, we studied the effect of resveratrol UVB-mediated
modulations on serine-32 phorphorylation of IkBa. Our re-
sults (Figure 5) clearly showed that UVB exposure of the
keratinocytes results in increased phosphorylation of IkBa
at serine-32, whereas resveratrol pretreatment results in a
significant dose- and time-dependent inhibition of the
phosphorylation.
IkB is clearly an important signaling molecule in skin
biology. Mice null for IkB are seemingly normal at birth, but
they eventually runt and develop dermatitis (see Ref. [12] ).
Marked alterations in epidermal morphology include ex-
cessive proliferation of basal keratinocytes and a paucity of
keratohyalin granules that typify the granular layer, a late-
stage feature of terminal differentiation. Additionally, keratin
14, a marker of the proliferative compartment of the
epidermis, and keratin 16 ( typically induced in a variety
of hyperproliferative skin disorders) are expressed in the
suprabasal compartment of IkBa/ epidermis, normally
reserved for terminally differentiating cells (see Ref. [12] ).
Thus, our studies showing that resveratrol pretreatment
to the keratinocytes causes the restoration of UVB-
mediated phosphorylative degradation of IkBa is an impor-
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Figure 6. Effect of resveratrol on UVB - induced activation of IKK. The normal human keratinocytes were treated with resveratrol ( 5, 10, and 25 M for 24 hours for
dose -dependent studies or 5 M for 12, 24, and 48 hours for time -dependent studies ) after which the cells were washed and exposed to UVB radiation in PBS. Six
hours following UVB exposure, the postnuclear lysates ( cytosol ) were prepared. The immunoblot analysis was performed using appropriate antibodies as described
under Materials and Methods. For every immunoblot, equal loading of protein was confirmed by stripping the blot and reprobing with  - actin antibody ( data not
shown ). The data shown here are from representative experiments repeated four times with similar results.
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tant information, which implies that this naturally occurring
agent may provide protection from cutaneous damages
including skin cancer.
In fact, numerous extracellular stimuli can activate NF-kB
through signaling pathways, which activate an IKK complex
[34] that phosphorylates IkB on serine-32 and serine-36.
The phosphorylation of IkB leads to its ubiquitination and
ultimate degradation by the proteasome [7–12], allowing
NF-kB to translocate to the nucleus where it activates the
expression of genes. Activation of the NF-kB/Rel family of
transcription factors regulates the expression of genes that
participate in pathways involving inflammation, cell prolifer-
ation, and apoptosis [7–12], including the inflammatory
mediators such as COX-2 [35]. Because our studies have
shown that resveratrol blocks UVB-mediated activation of
NF-kB in keratinocytes and that this effect is mediated
through a phosphorylative degradation of IkBa, we asked
whether or not IKK plays a role in this process. As shown in
Figure 6, our data demonstrated that resveratrol indeed
inhibits the UVB-mediated upregulation in the levels of IKK,
in a dose- as well as time-dependent fashion. IKK is the key
regulatory complex required for NF-kB activation of gene
transcription [34].
Taken together, our study suggests that NF-kB pathway
plays a critical role in the chemopreventive effects of
resveratrol against the adverse effects of UV radiation in-
cluding photocarcinogenesis. A simplified explanation of
the mechanism of resveratrol action is given in Figure 7.
Thus, our results, for the first time, provide a molecular
basis to explain the photochemopreventive properties of
resveratrol. The upstream molecular target of resveratrol
action is not known at this time. However, the involvement
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Figure 7. Schematic representation of the mechanism of the chemopreventive effects of resveratrol against UVB-mediated damages.
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of NF-kB–inducing kinase or MEKK1 is an intriguing possi-
bility in this direction.
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